Chimay Plastic Surgery Clinic, Taipei
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 104
- Locations
- 1
- Primary Endpoint
- Quality of recovery, postoperative day one
Study Overview
Brief Summary
Among aesthetic or cosmetic surgeries, breast augmentation was the most frequently performed and the endoscopic transaxillary approach has become the preferred incision for Asian women. As breast augmentation must be performed under general anesthesia accompanied by its effects and potential complications, types of general anesthesia may affect the quality of recovery. Currently, the two most common techniques of general anesthesia are inhalation anesthesia (IH) and total intravenous anesthesia (TIVA). The effects of these types of general anesthesia on the quality of recovery have been investigated for numerous surgical procedures. However, no prior studies have analyzed different types of anesthesia used for performing transaxillary endoscopic breast augmentation. This prospective, parallel, randomized controlled study will evaluate the effects of inhalation anesthesia vs. total intravenous anesthesia on the quality of recovery in patients undergoing transaxillary endoscopic breast augmentation.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 20 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients are appropriate for undergoing transaxillary endoscopic breast augmentation
- •Age between 20-65 years
- •Physical Status I or II as defined by the American Society of Anesthesiologists (ASA) Physical Status Classification System
Exclusion Criteria
- •Having difficulty reading or hearing
- •Diagnosed with addictive disorder
- •Diagnosed with psychiatric disorder
- •Physical Status III-VI as defined by the ASA Physical Status Classification System
- •Presence of acute infection or inflammatory condition (e.g., fever).
Arms & Interventions
IH group
Inhalation anesthesia will be given during transaxillary endoscopic breast augmentation.
Intervention: Desflurane (Drug)
TIVA group
Total intravenous anesthesia will be given during transaxillary endoscopic breast augmentation.
Intervention: Propofol (Drug)
Outcomes
Primary Outcomes
Quality of recovery, postoperative day one
Time Frame: On the 1st postoperative day
Quality of recovery is assessed by the 15-item Quality of Recovery (QoR-15) questionnaire. The total score of the 15-item QoR ranges from 0 to 150, and a higher score indicates a better outcome.
Quality of recovery, postoperative day two
Time Frame: On the 2nd postoperative day
Quality of recovery is assessed by the 15-item Quality of Recovery (QoR-15) questionnaire. The total score of the 15-item QoR ranges from 0 to 150, and a higher score indicates a better outcome.
Secondary Outcomes
No secondary outcomes reported
Investigators
Chih-Cheng Hung
Superintendent
Chimay Plastic Surgery Clinic